Structured patient insight that strengthens decisions under scrutiny.
Patient engagement is not a communications exercise. It is a strategic input.
In high-stakes environments, patient insight must inform regulatory positioning, clinical interpretation, value arguments, and investor narratives. When lived experience is bolted on late, credibility weakens. When it is integrated early, strategy strengthens.
We work with biotech and medtech leadership teams to structure patient engagement in a way that supports governance, compliance, and commercial clarity, not sentiment.
Our Services Include:
- Early-stage patient landscape and stakeholder mapping
- Advisory board design aligned to regulatory and access objectives
- Structured integration of patient insight into clinical and HEOR strategy
- Evidence-based patient materials grounded in medical accuracy
- Governance-compliant engagement frameworks and documentation
These services are delivered within Amodaia’s Narrative Integrity Framework™, ensuring patient insight reinforces regulatory credibility, medical clarity, access positioning, and commercial strategy, not contradicts it.
Case Studies
Biotech | Europe – Patient Insight Integration for Rare Disease Programme
Challenge: A development-stage biotech sought to incorporate patient advocacy perspectives but lacked a structured framework to ensure insights informed regulatory and access strategy.
Solution: Conducted stakeholder mapping, facilitated structured advisory input, aligned outputs to clinical endpoints and value narrative, and integrated findings into regulatory and payer materials.
Impact: Clearer trial positioning, stronger payer-relevant endpoints, and a more coherent cross-functional narrative under scrutiny.
